Pacira BioSciences, Inc. (PCRX) — Financial Flexibility Index
Pacira BioSciences, Inc. (PCRX) has a Financial Flexibility Index of 0.10x as of June 2026. Free cash flow of $58.80 Million (operating CF $57.46 Million minus capex $1.34 Million) represents 0% of total liabilities ($572.01 Million). Check PCRX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pacira BioSciences, Inc. Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Pacira BioSciences, Inc. across 18 annual periods. For the full cash flow conversion analysis, see Pacira BioSciences, Inc. operating cash flow efficiency.
Annual Financial Flexibility Index for Pacira BioSciences, Inc. (2008–2025)
Year-by-year free cash flow to debt coverage for Pacira BioSciences, Inc.. Explore cash flow to debt ratio of Pacira BioSciences, Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | $167.33 Million | $151.99 Million | $571.81 Million | ▲ +13.4% |
| 2024 | 0.26x | $200.03 Million | $189.39 Million | $775.17 Million | ▲ +7.0% |
| 2023 | 0.24x | $169.81 Million | $154.65 Million | $704.26 Million | ▲ +24.6% |
| 2022 | 0.19x | $175.35 Million | $145.27 Million | $906.19 Million | ▲ +51.7% |
| 2021 | 0.13x | $171.58 Million | $125.72 Million | $1.34 Billion | ▼ -27.3% |
| 2020 | 0.18x | $114.83 Million | $77.03 Million | $654.83 Million | ▲ +3.5% |
| 2019 | 0.17x | $80.68 Million | $70.52 Million | $476.12 Million | ▼ -1.6% |
| 2018 | 0.17x | $63.38 Million | $48.87 Million | $368.13 Million | ▲ +62.1% |
| 2017 | 0.11x | $37.05 Million | $17.79 Million | $348.89 Million | ▼ -68.5% |
| 2016 | 0.34x | $58.16 Million | $33.45 Million | $172.49 Million | ▼ -17.8% |
| 2015 | 0.41x | $70.27 Million | $29.00 Million | $171.23 Million | ▲ +34.2% |
| 2014 | 0.31x | $47.36 Million | $25.47 Million | $154.93 Million | ▲ +229.2% |
| 2013 | -0.24x | $-30.42 Million | $-43.22 Million | $128.57 Million | ▲ +78.9% |
| 2012 | -1.12x | $-51.87 Million | $-70.13 Million | $46.20 Million | ▼ -194.9% |
| 2011 | -0.38x | $-24.83 Million | $-31.00 Million | $65.22 Million | ▼ -141.7% |
| 2010 | -0.16x | $-18.11 Million | $-24.88 Million | $114.94 Million | ▲ +31.2% |
| 2009 | -0.23x | $-15.33 Million | $-20.84 Million | $66.90 Million | ▲ +57.8% |
| 2008 | -0.54x | $-23.35 Million | $-29.19 Million | $43.05 Million | — |